Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer
Public ClinicalTrials.gov record NCT00657904. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Double-Blind Comparative Trial of Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer.
Study identification
- NCT ID
- NCT00657904
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 3,618 participants
Conditions and interventions
Conditions
Interventions
- Bicalutamide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 1995
- Primary completion
- Jun 30, 2008
- Completion
- Jul 31, 2008
- Last update posted
- Jun 5, 2012
1995 – 2008
United States locations
- U.S. sites
- 72
- U.S. states
- 34
- U.S. cities
- 72
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Mobile | Alabama | — | — |
| Research Site | Scottsdale | Arizona | — | — |
| Research Site | Tucson | Arizona | — | — |
| Research Site | Berkeley | California | — | — |
| Research Site | Laguna Woods | California | — | — |
| Research Site | Newport Beach | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | San Francisco | California | — | — |
| Research Site | Santa Monica | California | — | — |
| Research Site | Thousand Oaks | California | — | — |
| Research Site | Torrance | California | — | — |
| Research Site | Van Nuys | California | — | — |
| Research Site | Denver | Colorado | — | — |
| Research Site | Middlebury | Connecticut | — | — |
| Research Site | New Haven | Connecticut | — | — |
| Research Site | Washington D.C. | District of Columbia | — | — |
| Research Site | Aventura | Florida | — | — |
| Research Site | Bay Pines | Florida | — | — |
| Research Site | Boca Raton | Florida | — | — |
| Research Site | Daytona Beach | Florida | — | — |
| Research Site | Fort Myers | Florida | — | — |
| Research Site | Gainesville | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Ocala | Florida | — | — |
| Research Site | Saint Augustine | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Fort Wayne | Indiana | — | — |
| Research Site | Greenwood | Indiana | — | — |
| Research Site | Iowa City | Iowa | — | — |
| Research Site | Kansas City | Kansas | — | — |
| Research Site | Louisville | Kentucky | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Greenbelt | Maryland | — | — |
| Research Site | Rockville | Maryland | — | — |
| Research Site | Burlington | Massachusetts | — | — |
| Research Site | Newtown | Massachusetts | — | — |
| Research Site | Ann Arbor | Michigan | — | — |
| Research Site | Detroit | Michigan | — | — |
| Research Site | Rochester | Minnesota | — | — |
| Research Site | Hattiesburg | Mississippi | — | — |
| Research Site | Jackson | Mississippi | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Omaha | Nebraska | — | — |
| Research Site | Lebanon | New Hampshire | — | — |
| Research Site | Albany | New York | — | — |
| Research Site | Manhasset | New York | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Syracuse | New York | — | — |
| Research Site | The Bronx | New York | — | — |
| Research Site | Asheville | North Carolina | — | — |
| Research Site | Durham | North Carolina | — | — |
| Research Site | Raleigh | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Lancaster | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Cordova | Tennessee | — | — |
| Research Site | Nashville | Tennessee | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Salt Lake City | Utah | — | — |
| Research Site | Danville | Virginia | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Virginia Beach | Virginia | — | — |
| Research Site | Seattle | Washington | — | — |
| Research Site | Madison | Wisconsin | — | — |
| Research Site | Milwaukee | Wisconsin | — | — |
| Research Site | Cheyenne | Wyoming | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00657904, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 5, 2012 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00657904 live on ClinicalTrials.gov.